Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 16.268% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) NCCNc1ccc([N+](=O)[O-])c(NC2CC2)c1
(b) COc1ccc(/C=C/C(=O)OCC(=O)NC2CCS(=O)(=O)C2)cc1
(c) CCn1c(SCC(=O)O)nnc1-c1ccc(S(=O)(=O)N2CCCC2)cc1
(d) CCn1c(COc2cccc(C)c2)nnc1SCC(=O)CC(=O)Nc1ccccc1OC
(e) CCn1cc(CN2CCCC(C(=O)Nc3cccc(-c4cc5ccccc5[nH]4)c3)C2)c(C)n1
Answer: c. CCn1c(SCC(=O)O)nnc1-c1ccc(S(=O)(=O)N2CCCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(SCC(=O)O)nnc1-c1ccc(S(=O)(=O)N2CCCC2)cc1
CCn1c(SCC(=O)O)nnc1-c1ccc(S(=O)(=O)N2CCCC2)cc1
2-[[4-ethyl-5-(4-pyrrolidin-1-ylsulfonylphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid